EUVIMEDEUVIMED entdecken
Crossref

Mesenchymal Stem Cell-Based Biomimetic Liposome for Targeted Treatment of Rheumatoid Arthritis

Lan Ma, Honghui Wu, Jian Cao, Nan Zhang iD, Yaosheng Li, Juanjuan Zheng, Xinchi Jiang, Jianqing Gao iD

ACS Applied Materials & Interfaces · 2024

DOI: 10.1021/acsami.4c09080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2024. Verfasst von Lan Ma und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Liposomes, Arthritis, Rheumatoid, Dexamethasone. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsLiposomesArthritis, RheumatoidDexamethasoneDrug Delivery SystemsHumansAnimalsMiceHuman Umbilical Vein Endothelial CellsMice, Inbred BALB CMice, Inbred DBAMaleBiomimeticsCartilage

Stichwörter der Autor:innen

LFA-1/ICAM-1biomimetic nanocarriermacrophage targetingmesenchymal stem cell membranerheumatoid arthritis

Substanzen

LiposomesDexamethasone

Autor:innen und Institutionen

  • State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • College of Pharmacy, Inner Mongolia Medical University, Chilechuan Dairy Economic Development Zone, Hohhot, Inner Mongolia Autonomous Region 010110, China.
  • Jinhua Institute of Zhejiang University, Jinhua 321002, China.
  • Department of Pharmaceutics, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

ORCID-Profile: Nan Zhang, Jianqing Gao

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Ma, L., Wu, H., Cao, J., Zhang, N., Li, Y., Zheng, J., Jiang, X., & Gao, J. (2024). Mesenchymal Stem Cell-Based Biomimetic Liposome for Targeted Treatment of Rheumatoid Arthritis. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c09080

Vancouver

Ma L, Wu H, Cao J, Zhang N, Li Y, Zheng J, et al. Mesenchymal Stem Cell-Based Biomimetic Liposome for Targeted Treatment of Rheumatoid Arthritis. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c09080

BibTeX
@article{Ma2024,
  author = {Ma, Lan and Wu, Honghui and Cao, Jian and Zhang, Nan and Li, Yaosheng and Zheng, Juanjuan and Jiang, Xinchi and Gao, Jianqing},
  title = {Mesenchymal Stem Cell-Based Biomimetic Liposome for Targeted Treatment of Rheumatoid Arthritis},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c09080}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche